Belluscura plc (AIM:BELL)
London
· Delayed Price · Currency is GBP · Price in GBX 0.7500
+0.0250 (3.45%)
Jul 1, 2025, 7:30 AM GMT+1
Belluscura Market Cap
Belluscura has a market cap or net worth of 3.01 million as of July 9, 2025. Its market cap has decreased by -85.97% in one year.
Market Cap
3.01M
Enterprise Value
2.32M
Revenue
1.43M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.75
Market Cap Chart
Since May 28, 2021, Belluscura's market cap has decreased from 60.02M to 3.01M, a decrease of -94.99%. That is a compound annual growth rate of -51.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2025 | 3.01M | -80.68% |
| Dec 31, 2024 | 15.58M | -50.75% |
| Dec 29, 2023 | 31.63M | -60.74% |
| Dec 30, 2022 | 80.58M | -36.80% |
| Dec 31, 2021 | 127.50M | 112.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 160.28B |
| GSK plc | 56.85B |
| Haleon | 33.95B |
| Smith & Nephew | 9.73B |
| ConvaTec Group | 5.40B |
| Hikma Pharmaceuticals | 4.36B |
| HUTCHMED (China) | 1.96B |
| Oxford Nanopore Technologies | 1.42B |